Abstract: An air conditioning apparatus is equipped with an indoor fan, an indoor heat exchanger, and a control unit. The indoor heat exchanger generates conditioned air by exchanging heat between refrigerant and room air. The control unit sets operating modes. The control unit controls the rotational speed of the indoor fan. More specifically, in a case where the operating mode has been switched from one to the other of a normal heating mode and a hot air mode in which the conditioned air higher in temperature than in the normal heating mode is generated, the control unit lowers the rotational speed at a second rate that is slower than a first rate which is a rate of decrease in the rotational speed in a case where the operating mode is set to the normal heating mode.

Abstract: An air conditioning apparatus is equipped with an indoor fan, an indoor heat exchanger, and a control unit. The indoor heat exchanger generates conditioned air by exchanging heat between refrigerant and room air. The control unit sets operating modes. The control unit controls the rotational speed of the indoor fan. More specifically, in a case where the operating mode has been switched from one to the other of a normal heating mode and a hot air mode in which the conditioned air higher in temperature than in the normal heating mode is generated, the control unit lowers the rotational speed at a second rate that is slower than a first rate which is a rate of decrease in the rotational speed in a case where the operating mode is set to the normal heating mode.

Abstract: A compound which is able to activate a calcium receptor can be used as an active ingredient of a prophylactic or therapeutic agent for treating diarrhea. The compound can be a peptide such as ?-Glu-X-Gly (X represents an amino acid or an amino acid derivative), ?-Glu-Val-Y (Y represents an amino acid or an amino acid derivative), ?-Glu-Ala, ?-Glu-Gly, ?-Glu-Cys, ?-Glu-Met, ?-Glu-Thr, ?-Glu-Val, ?-Glu-Orn, Asp-Gly, Cys-Gly, Cys-Met, Glu-Cys, Gly-Cys, Leu-Asp, ?-Glu-Met(O), ?-Glu-?-Glu-Val, ?-Glu-Val-NH2, ?-Glu-Val-ol, ?-Glu-Ser, ?-Glu-Tau, ?-Glu-Cys(S-Me)(O), ?-Glu-Leu, ?-Glu-Ile, ?-Glu-t-Leu, and ?-Glu-Cys(S-Me).

Abstract: The present invention provides a prophylactic/therapeutic agent for an allergic disease caused by Th2 cell-polarized activation, which comprises at least one kind selected from a branched amino acid, glycine, serine, arginine, a keto acid thereof and a salt thereof. Because the prophylactic/therapeutic agent of the present invention produces almost no side effects, it can be safely ingested routinely and can be taken for a long time. When the prophylactic/therapeutic agent of the present invention is used in combination with an anti-inflammatory drug, the dose of the anti-inflammatory drug can be reduced. Hence, the prophylactic/therapeutic agent of the present invention is useful for the prevention or treatment of an allergic disease caused by Th2 cell-polarized activation. The prophylactic/therapeutic agent of the present invention is particularly effective on bronchial asthma and pulmonary fibrosis that accompanies bronchial asthma.

Abstract: The present invention relates to preventives/remedies for inflammatory diseases containing ornithine and/or branched amino acid(s) and a method of treating or preventing an inflammatory disease by administering to a subject in need thereof a composition containing the same.